Convergent Genomics

Convergent Genomics is a precision medicine company that combines advances in genomics and machine learning to detect cancer early and non-invasively. Convergent is a leader in applying these technologies for use in liquid biopsy from urine. Using genomic data, our products further integrate clinical scenarios and scientific literature to richly contextualize a patient’s specific risk and enable unique data-driven decision-making. Our Mission: Transforming cancer care through clear and actionable insights.